Join to View Full Profile
3601 21st Ave SNashville, TN 37232
Phone+1 615-322-5000
Dr. Lo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Justin Lo is an oncology specialist based in Nashville, TN, serving as an Instructor at Vanderbilt University Medical Center since 2023. He completed his MD-PhD at Harvard Medical School and MIT in 2017, followed by a residency in Internal Medicine and a fellowship in hematology and medical oncology at Vanderbilt University Medical Center. Dr. Lo's research is focused on developing new drug delivery technologies and combination strategies for treatment of GI cancers.
Education & Training
Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 2019 - 2023- Vanderbilt University Medical CenterResidency, Internal Medicine, 2017 - 2019
Harvard Medical SchoolClass of 2017
Massachusetts Institute of TechnologyPhD, 2010 - 2015
Certifications & Licensure
TN State Medical License 2022 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Induction of Triple-Negative Breast Cancer Cell Death and Chemosensitivity Using mTORC2-Directed RNAi Nanomedicine.Shrusti S Patel, Rebecca S Cook, Justin H Lo, Fiona K Cherry, Ella N Hoogenboezem
Cancer Research Communications. 2025-03-01 - 8 citationsStructural optimization of siRNA conjugates for albumin binding achieves effective MCL1-directed cancer therapy.Ella N Hoogenboezem, Shrusti S Patel, Justin H Lo, Ashley B Cavnar, Lauren M Babb
Nature Communications. 2024-02-21 - 21 citationsImmunotherapy in Biliary Tract Cancers: Current Standard-of-Care and Emerging Strategies.Justin H Lo, Rajiv Agarwal, Laura W Goff, Thatcher R Heumann
Cancers. 2023-06-23
Press Mentions
AACR and FDA Introduce New Fellowship ProgramDecember 10th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
